EMD-32161
SARS-CoV-2 spike protein (1-up RBD) on Quantifoil grid
EMD-32161
Single-particle3.23 Å
Deposition: 11/11/2021Map released: 16/11/2022
Last modified: 13/12/2023
Sample Organism:
Severe acute respiratory syndrome coronavirus 2
Sample: SARS-CoV-2 spike protein
Deposition Authors: Fujita J
,
Makino F ,
Asahara H ,
Moriguchi M ,
Kumano S,
Anzai I ,
Kishikawa J ,
Matsuura Y ,
Kato T ,
Namba K ,
Inoue T
Sample: SARS-CoV-2 spike protein
Deposition Authors: Fujita J
,
Makino F ,
Asahara H ,
Moriguchi M ,
Kumano S,
Anzai I ,
Kishikawa J ,
Matsuura Y ,
Kato T ,
Namba K ,
Inoue T
Epoxidized graphene grid for highly efficient high-resolution cryoEM structural analysis.
Fujita J ,
Makino F ,
Asahara H ,
Moriguchi M ,
Kumano S,
Anzai I ,
Kishikawa JI ,
Matsuura Y ,
Kato T ,
Namba K ,
Inoue T
(2023) Sci Rep , 13 , 2279 - 2279
,
Makino F ,
Asahara H ,
Moriguchi M ,
Kumano S,
Anzai I ,
Kishikawa JI ,
Matsuura Y ,
Kato T ,
Namba K ,
Inoue T
(2023) Sci Rep , 13 , 2279 - 2279
Grant Support:
- Japan Science and Technology: JPMJOP1861 (Japan)
- New Energy and Industrial Technology Development Organization (NEDO): 16102003-0 (Japan)
- New Energy and Industrial Technology Development Organization (NEDO): 17101509-0 (Japan)
- Japan Society for the Promotion of Science (JSPS): JP25000013 (Japan)
- Japan Society for the Promotion of Science (JSPS): JP20K22630 (Japan)
- Japan Agency for Medical Research and Development (AMED): JP19am0101117 (Japan)
- Japan Agency for Medical Research and Development (AMED): JP17pc0101020 (Japan)